日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

靶向从头嘧啶合成会使 PARP 抑制剂耐药的卵巢癌对铜介导的 ATR 失活变得脆弱。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-70001-5
Nan Yabing, Wang Kunyu, Hu Menghan, Luo Qingyu, Wu Xiaowei, Yu Xiao, Zhou Xuantong, Chen Li, Li Bin, Cui Zhumei, Liu Zhihua
卵巢癌
肿瘤
ATR
PARP
发表日期：2026
文献求助 收藏

A comment on "A multi-modal model integrating MRI habitat and clinicopathology to predict platinum sensitivity in patients with high-grade serous ovarian cancer: a diagnostic study"

关于“整合MRI生境和临床病理的多模态模型预测高级别浆液性卵巢癌患者铂类药物敏感性：一项诊断研究”的评论

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003387
Shan, Yuping; Cui, Zhumei; Yin, Guangjie
肿瘤
肿瘤免疫
卵巢癌
发表日期：2026
文献求助 收藏

A commentary on "Simplifying surgical criteria for early-stage cervical cancer: prognostic equivalence of total vs. radical hysterectomy in a retrospective SEER cohort analysis"

对“简化早期宫颈癌手术标准：回顾性 SEER 队列分析中全子宫切除术与根治性子宫切除术的预后等效性”的评论

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000003393
Shan, Yuping; Cui, Zhumei; Yin, Guangjie
宫颈癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Targeting neutrophil-driven immunosuppression: A strategy to overcome immune checkpoint inhibitor resistance

靶向中性粒细胞介导的免疫抑制：克服免疫检查点抑制剂耐药性的策略

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70582
Ning, Ying; Lei, Ke; Gao, Xinyan; Kong, Yan; Shan, Yuping; Tian, Tian; Cui, Zhumei; Ren, He
细胞生物学
中性粒细胞
粒细胞
免疫/内分泌
发表日期：2026
文献求助 收藏

Prognostic comparison of fertility-sparing surgery and hysterectomy in early-stage ovarian clear cell carcinoma: a population-based analysis

早期卵巢透明细胞癌保留生育功能手术与子宫切除术的预后比较：一项基于人群的分析

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-026-08310-9
Ning, Ying; Xu, Xiaonuo; Gao, Xinyan; Kong, Yan; Liu, Xiangyu; Wang, Yan; Lei, Ke; Tian, Tian; Cui, Zhumei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

The prognosis of patients with locally advanced cervical cancer undergoing surgical versus non-surgical treatment: a retrospective cohort study based on SEER database and a single-center data

局部晚期宫颈癌患者接受手术治疗与非手术治疗的预后：一项基于SEER数据库和单中心数据的回顾性队列研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000002098
Gao, Xinyan; Kong, Yan; Ning, Ying; Tian, Tian; Gai, Xiaojing; Lei, Ke; Cui, Zhumei
宫颈癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Transferrin Receptor Promotes Endometrial Cancer Proliferation by Activating the Iron-Dependent PI3K/AKT/mTOR Signaling Pathway.

转铁蛋白受体通过激活铁依赖性PI3K/AKT/mTOR信号通路促进子宫内膜癌增殖

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70015
Yang Yufei, Ning Ying, Chen Yu, Tian Tian, Gao Xinyan, Kong Yan, Lei Ke, Cui Zhumei
肿瘤
PI3K/Akt
mTOR
发表日期：2025
文献求助 收藏

Clinical characteristics of endometrial cancers with microsatellite instability-high and BRCA1/2 mutations

具有微卫星不稳定性高和BRCA1/2突变的子宫内膜癌的临床特征

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1685642
Shan, Yuping; Wang, Yan; Huang, Liying; Li, Guangqi; Cui, Zhumei; Xing, Xiaoming; Yin, Guangjie
BRCA1
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Cervical metastasis of breast cancer: a case report and review of the literature

乳腺癌颈部转移：病例报告及文献综述

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-025-02500-8
Shan, Yuping; Hou, Feng; Wang, Yan; Han, Yi; Cui, Zhumei; Yin, Guangjie
肿瘤免疫
肿瘤
乳腺癌
发表日期：2025
文献求助 收藏

Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases

对于具有一项中危因素的IA-IIA期宫颈腺癌（FIGO 2018分期）患者，术后辅助治疗：一项纳入63926例患者的多中心回顾性队列研究

期刊:World Journal of Surgical Oncology
影响因子:2.5
doi:10.1186/s12957-025-03739-9
Fu, Jiaxin; Liang, Cong; Sun, Lixin; Zhao, Hongwei; Cui, Zhumei; Lang, Jinghe; Chen, Chunlin; Liu, Ping
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏